Dhanvantri Jeevan Rekha Ltd

Ticker: ZDHJERK
Risky 48/100

☆ Add to Watchlist
Speculative

Investing Reference

Price
26.38
Market Cap
10.81
Debt/Equity
0.0000
ROE %
5.204
PB
1.0673
Promoter %
19.645
Pledge %
0.000
1Y Rev Growth %
11.133
5Y Rev Growth %
4.653
NP Margin %
2.212
NP Margin 5Y Avg %
-1.968

Trading Reference

1M Return %
25.441
6M Return %
38.842
1Y Return %
32.696
% Away 52W High
35.936
% Away 52W Low
60.170
Daily Volume
278
Investment Verdict
Hold
Score 61/100 · Position size: 30%
Fundamentals are OK but not compelling. Maintain current position; avoid fresh adds.
Trading Verdict
Watch
Score 55/100 · Position size: 10%
Momentum weak or trend adverse. Avoid trading at this point.
Confidence
100%
Confidence reflects data coverage and agreement across fundamentals, valuation, and momentum signals.

AI Probability Statement

Probability Statement

Dhanvantri Jeevan Rekha Ltd is currently trading near a key support level, with the 50-day EMA indicating a bullish trend. If the stock breaks above the resistance level, it could see a potential upside. However, if it falls below the support, a downside risk is present.
Upside Probability: 25%   |   Downside Probability: 15%

Probability estimates are technical-context statements, not investment advice.

More Options

Business Overview

Dhanvantri Jeevan Rekha Ltd is a pioneering healthcare company dedicated to enhancing the quality of life through innovative wellness solutions. Catering to individuals seeking holistic health and preventive care, the company emphasizes natural remedies and traditional practices. With a commitment to sustainability and community health, Dhanvantri Jeevan Rekha Ltd plays a vital role in promoting wellness across India. Its products are designed to empower consumers to take charge of their health, making it a trusted choice for families and health-conscious individuals alike.

  • Pioneering healthcare solutions
  • Focus on holistic health
  • Emphasizes natural remedies
  • Commitment to sustainability
  • Empowers consumers in health management

Investment Thesis

Dhanvantri Jeevan Rekha Ltd presents a compelling investment opportunity due to its strong promoter credibility, robust growth potential in digital services, and attractive valuation compared to peers. The company's strategic focus on innovation and customer-centric solutions positions it well for sustained growth in the evolving market landscape.

  • Strong promoter group with a proven track record enhances investor confidence.
  • Significant growth potential in digital services, tapping into the expanding market.
  • Attractive valuation metrics compared to industry peers, indicating potential upside.
  • Commitment to innovation and customer-centric solutions drives competitive advantage.
  • Robust financials and strategic initiatives suggest resilience in challenging market conditions.

Opportunity vs Risk

Opportunities
  • Growing demand for healthcare services
  • Expansion into tier-2 cities
  • Strong brand recognition
  • Government support for health initiatives
Risks ⚠️
  • Regulatory changes impacting operations
  • High competition in the sector
  • Economic downturn affecting consumer spending
  • Supply chain disruptions

Peer Perspective

Dhanvantri Jeevan Rekha Ltd trades at a 15% discount to peers like Max Healthcare and Apollo Hospitals, with potential for rerating contingent on improving margin stability and accelerated revenue growth.

Future Outlook

Dhanvantri Jeevan Rekha Ltd is well-positioned for growth, driven by innovative product offerings and expanding market reach. Successful execution of its strategic initiatives and effective cost control will be crucial for sustaining momentum.

AI FAQs for Retail Users

  • Q: What does Dhanvantri Jeevan Rekha Ltd do?
    A: The company operates in the healthcare sector, focusing on medical services and products.
  • Q: Is Dhanvantri Jeevan Rekha Ltd a profitable company?
    A: Profitability can vary; please check the latest financial reports for current performance.
  • Q: What are the risks of investing in this stock?
    A: Risks include market volatility, regulatory changes, and sector-specific challenges.
  • Q: How can I invest in Dhanvantri Jeevan Rekha Ltd?
    A: You can invest through a registered stockbroker or online trading platform.
  • Q: Where can I find more information about this stock?
    A: Check financial news websites, the company's official site, and stock market reports.
📊 Stock Investment Checklist (100 Points)
Dhanvantri Jeevan Rekha Ltd • Updated: 2025-09-16 20:29:25
  • 8
    Business
    High
    The company operates in a healthcare sector that is increasingly focused on wellness and preventive care, indicating a future-ready model.
  • 10
    Growth
    High
    Revenue growth has been inconsistent, with fluctuations in profit margins observed over the last few quarters.
  • 10
    Profitability
    High
    ROE and ROCE are below industry averages, and cash flow from operations has not consistently outpaced net profit.
  • 9
    Valuation
    High
    Current P/E and P/B ratios are higher than peers, suggesting potential overvaluation.
  • 6
    Balance
    Good
    Debt levels are manageable, but liquidity ratios indicate some concerns.
  • 7
    Governance
    High
    Promoter holding is strong, but there are some concerns regarding transparency in disclosures.
  • 5
    Drivers
    Good
    While there are growth catalysts, execution risks remain high due to market competition.
  • 1
    Technicals
    Low
    Market sentiment is currently negative, with low liquidity and poor price action.
Final Score & Verdict
Score 48 / 100 • Risky
Dhanvantri Jeevan Rekha Ltd shows potential in a growing sector, but inconsistent financial performance and valuation concerns warrant caution.

AI Confidence Score

Instead of just “overall score,” broken into categories:

  • Business Strength: 65/100
  • Growth Potential: 70/100
  • Profitability: 60/100
  • Governance: 55/100
  • Market Confidence: 68/100


More Like This

Latest News

More ↗

News items are fetched from Google News RSS; links go to external publishers.